You have long known the values and promises of Dr. Reddy’s Laboratories.

We, as a part of the organization, extend our services into the world of Biologics, standing firm in the same belief that GOOD HEALTH CAN’T WAIT. Our guiding principles and our promises are a continuance of the 40-year-long legacy of Dr Reddy’s.

Dr. Reddy’s Heritage: A Truly Global Company

Years of Dr. Reddy’s Established in 1984 by Dr. Anji Reddy

R&D Centers

Global revenue in FY2024

Manufacturing Sites Including API, finished formulations, and biologics

Countries, a felt global presence

Employees from 50+ nationalities

Patients access our therapies every year

of the global revenue invested in Research and Development

We Are One.
United in Our Passion for Care

We at Dr. Reddy’s Biologics enable access to high-quality, cost-competitive biosimilars. The future we imagine is one where patients worldwide find ease in illness, every day. Our state-of-the-art manufacturing facilities and end-to-end capabilities bring this future within reach making us a leading biosimilars manufacturer.

Dr. Reddy’s Biologics Leadership Council

Sridevi Khambhampaty

Global Head of Biologics

(Ph.D. in Biological Sciences)

Seasoned biotech leader with over 22 years of experience in R&D, and strategic leadership.
Adept at driving sustainable growth in the biopharmaceutical sector (Shilpa Biologicals, Syngene International, Intas Pharmaceuticals, and Dr. Reddy’s Laboratories)
Successfully led teams in the development of innovative products, including recombinant proteins & mAbs, played a key role in advancing scientific innovation across organizations.

Go Back

Narendra Maharaj

Head of Clinical Development

(M.B.B.S. M.D in Pharmacology)

Drug development professional with over 27 years of experience in Pharmaceutical R & D, and CROs
Responsible for strategy and execution of global clinical trials
Contributed to development, approval and commercialization of various novel entities, generics and biologics products

Go Back

Vikas Kumar

Head of Product Development

(Ph.D. in Biochemistry and Molecular Biology)

Expert in biosimilars and biologics, specializing in biotechnology with 20+ years of experience.
Skilled in cell culture, downstream processes, analytical, bio-analytics and preclinical development and project management.

Go Back

Prasun Guha

Head of Regulatory Affairs

(M.Sc. in Biotechnology)

Pharmaceutical expert with over 20 years in regulatory affairs, secured biosimilar approvals globally, contributing significantly at SciGen BioPharma, Dr. Reddy's, Mylan, and Intas.

Go Back

Aditya Kumar Khanna

Global Head of Alliances, Commercial, Marketing and PMO – Biologics

(MBA in Pharmaceutical Management)

With 20+ years in pharmaceuticals, he leads global alliances and commercial strategy.
His expertise spans marketing, business development, alliance management, and international operations.

Go Back

Shwetanuj Saha

Global Head of Business Development, Strategy and Portfolio – Biologics

(PGDM in Management, Strategy, Marketing and SCM)

A seasoned executive with 17+ years in strategic planning, portfolio management, business development, and management systems.
Leads growth initiatives, bringing expertise from Deloitte and a strong background in pharma consulting.

Go Back

Anoop Rajashekar

Head of Quality for Biologics and CGT

(M.Sc. in Microbiology)

27 years of extensive experience in Quality Control, Quality Assurance, Data Integrity and Compliance.
Experience in building Inspection ready quality systems and driving operational excellence.
Brings expertise from leadership roles in Biocon Biologics, Novartis, Roche, Genentech and Lonza Biologics

Go Back

Bhupal Reddy Auothu

Head of CAR-T Site

(MBA in Strategic Management and Leadership)

Over 23 years of extensive experience in the biopharmaceutical and cell & gene therapy sectors, leads CAR-T site.
Brings expertise from key roles at GSK, Autolus, and a global network of CDMO/CMOs (Wuxi, Miltenyi, AGC, Samsung Biologics, HCATS/Minerva).
Ensures compliance with Good Manufacturing Practices (GMP), along with strategic Technology Evaluation & Implementation and Manufacturing Scale-Out.

Go Back

Tiyash Mazumder Bagchi

Head of Human Resources

(MPM in Human Resources)

Accomplished People & Organization leader with 20+ years of progressive experience across the pharma value chain.
Has led programs across Manufacturing, R&D, Biosimilars & Commercial business within Dr Reddy’s.
Expertise in building strategic business partnerships, talent advisory & driving organizational transformation for growth.
Has led multiple large scale change initiatives & cultivated inclusive & high performing cultures.

Go Back

Amit Agarwal

Head of Finance – Hor. 2, M&A and Biologics

(CA, CS, CPA)

23+ years of in-depth experience encompassing accounting, auditing, taxation, financial planning & analytics, business strategy, investor relations, ESG, M&A and performance management.
Experienced chartered accountant, worked with Deloitte and since 2007 has been working in different roles with Dr. Reddy’s.

Go Back

Jerome Gnanaprakasam

Global Head of Projects, Engineering, EHS & Sustainability

(BE in Mechanical Engineering)

34+ years of extensive experience in engineering and capital projects, leads Projects, Engineering, EHS & Sustainability for Global Manufacturing Operations at Dr. Reddy's Laboratories.
Brings expertise from key roles at Glenmark Pharmaceuticals, Actavis (now Allergan), Serum Institute of India Limited, and Biopharm.

Go Back

Mekala Raghava Srinivas

Head of Supply Chain, India

(MBA in Supply Chain & Operations Management)

Over 17 years of experience in pharmaceutical quality management and regulatory compliance, leads Supply Chain India at Dr. Reddy's Laboratories.
Brings expertise from key roles at Flipkart, The Good Stuff Pvt Ltd, Reckitt, and Becton Dickinson.
Recognized for strategic leadership and contributions to elevating organizational quality standards and operational efficiency.

Go Back

Ramanathan Kalyanasundaram

Head of Drug Substance Operations, MSAT, Planning & Transformation

(MBA in Operations Management)

Over 28 years of experience across pharmaceutical and biopharmaceutical manufacturing, with deep expertise in biologics operations.
Brings global experience from Orchid Pharma, MSD Singapore, Alcon (Novartis), Amgen Singapore, and Reliance Life Sciences, with strengths in operational excellence, validation, technology transfer, and regulated market readiness.

Go Back

Saurabh Biswas

Head of Digital and Process Excellence (IPDO & Biologics) & R&D Transformation

(MBA in Advanced Business Analytics, Statistics)

With over a decade of experience at Dr. Reddy’s, he has moved within many roles, shaping a unique career from manager level to the global head of the department.

Go Back

Srinivas Rao Manipatruni

Senior Principal, Head of Digital & Process Excellence (Biologics)

(MBA in Supply Chain & Operations)

16+ years of diversified experience in architecting and scaling enterprise-wide core-digital systems and advanced analytics initiatives.
Brings cross‑industry expertise from Biocon, iD Fresh Food & Tech Mahindra.

Go Back

Dr. Reddy’s Global Management Council

Read about the leaders of the organisation worldwide at Dr. Reddy’s website.

Know More

Dr. Reddy’s Biologics – Purpose, Promise and History

Our Purpose

Our purpose of accelerating access to affordable and innovative medicines is instructed by our conviction that GOOD HEALTH CAN’T WAIT. With patients at the heart of our efforts, we are dedicated to ensuring they receive the right treatment at the right time – improving their health outcomes. Towards this goal, we strive to create savings within the patient community that can contribute to a sustainable healthcare system by expanding treatment options. Our mission, ultimately, is to enhance access to essential biologic medicines by offering high-quality, cost-effective biosimilars.

Our Promises

Our shared values ensure that any member of our organisation that you meet is upholding our five promises. This is what continues to position us as one of the leaders in biotechnology.

Addressing unmet patient needs

Bringing essential medicines within reach

Ensuring medicines  are available where needed

Working with partners to help them succeed

Helping patients manage disease better

Our History

Our Biologics heritage spans over 25 years since 1998 when Dr. Reddy’s Biologics was first established. Our journey from launching the first biosimilar product in 2001, to today as we invest further in our pipeline of lifesaving biologics and innovations, has unfolded inspiringly.

Commercial Biosimilar Products

Over Countries

Products in Pipeline

patient lives reached

Our Journey

Dr.Reddy's Biologics receives its first USFDA Approval
Receives U.S. FDA Approval for Rituximab Biosimilar after successful Pre-License Inspection (PLI) of it's Bachupally facility conducted by U.S. FDA